Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The use of phenylhydrazine hydrochloride in polycythæmia

Conclusions

  1. 1.

    A case of polycythæmia is herewith reported, showing the result of treatment by phenylhydrazine hydroehloride.

  2. 2.

    The daily intake of protein was limited to 50 grammes to offset the possibility of an elevation of the blood urea, during the period of intensive treatment.

  3. 3.

    It is suggested that this mode of treatment is quite safe in very many cases of polyeythæmia, and is more easily available than other forms of treatment.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Hofheinz:Dtches. Arch. f. Klin. Med., 1929, 163, 1.

  2. 2.

    Friedemann u. Deicher:Klin. Wchschr., 1929, 8, 385.

  3. 3.

    Hoppe-Seyler:Ztschr. f. Physiol. Chem., 1885, 11, 34.

  4. 4.

    Morawitz u. Pratt:Münch, med. Wchschr., 1908, ii, 1817.

  5. 6.

    Eppinger u. Kloss:Therap. Monaths., 1918, 32, 322.

  6. 6.

    Bryan:Trans. Phys. Mayo Clinic, 1927, viii, 58.

  7. 7.

    Brown and Giffin:Arch. Int. Med., 1926, 38, 321.

  8. 8.

    Allen and Giffin:Arch. Int. Med., 1928, 1, 676.Ibid., 677.

  9. 9.

    Giffin & Conner:Jo. Am. Med. Ass’n., 92, 18, 1505.

Download references

Additional information

From Limerick County Hospital, Croom.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Honan, M.S., Madden, V. The use of phenylhydrazine hydrochloride in polycythæmia. Ir J Med Sci 4, 671–673 (1929). https://doi.org/10.1007/BF02951292

Download citation